Good morning :)
Switch to
Place Order

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,000 cr, stock is ranked 267
Low RiskStock is 1.83x as volatile as Nifty
834.7012.05 (+1.46%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,000 cr, stock is ranked 267
Low RiskStock is 1.83x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
34.02
PB RatioPB Ratio
3.64
Dividend YieldDiv. Yield
0.64%
Sector PESector PE
37.57
Sector PBSector PB
5.03
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Nov 15, 2021

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

20182019202020212.232.222.022.160.700.640.460.44
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnNov 22, 2021

Natco Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

Natco Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

Press Release 
Announced OnNov 18, 2021

Natco Pharma Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "NATCO launches Tipanat tablets in India, for the treatment of advancedcolorectal and gastric cancer". | Download

Natco Pharma Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "NATCO launches Tipanat tablets in India, for the treatment of advancedcolorectal and gastric cancer". | Download

Cash Dividend 
Ex. DateNov 23, 2021

Interim 2 • Div/Share: ₹ 0.5

See all events